Loading...
Kanabo Group Plc
KNB.L•LSE
HealthcareMedical - Pharmaceuticals
$0.23
$-0.07(-25.00%)
Kanabo Group Plc (KNB.L) Stock Overview
Explore Kanabo Group Plc’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for KNB.LStats details for KNB.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for KNB.LAnalyst Recommendations details for KNB.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Kanabo Group Plc develops and distributes cannabis-derived products for medical patients. It also offers non- tetrahydrocannabinol products for cannabidiol consumers. The company offers its products under the Kanabo brand name. Kanabo Group Plc was founded in 2016 and is based in London, the United Kingdom. Kanabo Group Plc is a subsidiary of Altshuler Shaham Trusts Ltd.
CEO
Mr. Avihu Tamir
Employees
20
Headquarters
Churchill House, London
Founded
2017